On Tuesday morning Pfizer and its German partner company, BioNTech, announced human trials of a Wuhan coronavirus vaccine have started. Pfizer is one of the largest pharmaceutical companies in the United States. Officials are also laying out a timeline for when it will be available.
"Pfizer in its contribution to make a difference in the devastating pandemic has put together plans for having the vaccine in millions of doses...by October and the plans involve ramping up to tens-of-millions later this year and with the potential for hundreds-of-millions in 2021. It's a very quick plan," Pfizer Chief Scientific Officer Dr. Mikael Dolsten told CNBC. "We are now participants, healthy participants, in the U.S. and Germany."
BREAKING: Pfizer, BioNTech starting the dosing of the first U.S. participants in their clinical trial of their experimental vaccines for #COVID19— Squawk Box (@SquawkCNBC) May 5, 2020
Pfizer has put in place plans for having millions of doses of the vaccine by October, says Pfizer Chief of Research Mikael Dolsten. pic.twitter.com/6frV6O4vHq
Pharmaceutical giant Pfizer is testing four versions of a COVID-19 vaccine on patients. They hope to have a version ready by Fall.— John Lesinski for Congress (@johnforva) May 5, 2020
While we're still a long way off from eradicating this virus, it is encouraging to see a company with Pfizer's resources giving this their all.
Over the weekend President Trump said the United States could see a vaccine for Wuhan coronavirus by the end of the year.
"We are very confident we are going to have a vaccine by the end of this year, " Trump said during a town hall with Fox News. "We're pushing very hard and building supply lines."
"Many companies I think are close," he continued. "We're doing things at the FDA that have never happened before. We're getting approval."
Editor's Note: Want to support Townhall so we can keep telling the truth about China and the virus they unleashed on the world? Join Townhall VIP and use the promo code WUHAN to get 25% off VIP membership!